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Abstract 
We show that simple, commercially sourced n-channel silicon field-effect transistors 
(nFETs) operating under closed loop control exhibit an »3-fold improvement in pH readout 
resolution to (7.2±0.3)´10-3 at a bandwidth of 10 Hz when compared with the open loop 
operation commonly employed by integrated ion-sensitive field-effect transistors (ISFETs). We 
leveraged the improved nFET performance to measure the change in solution pH arising from 
the activity of a pathological form of the kinase Cdk5, an enzyme implicated in Alzheimer’s 
disease, and showed quantitative agreement with previous measurements. The improved pH 
resolution was realized while the devices were operated in a remote sensing configuration with 
the pH sensing element off-chip and connected electrically to the FET gate terminal. We 
compared these results with those measured by using a custom-built dual-gate 2D field-effect 
transistor (dg2DFET) fabricated with 2D semi-conducting MoS2 channels and a moderate device 
gain, a=8. Under identical solution conditions the pH resolution of the nFETs was only 2-fold 
worse than the dg2DFETs pH resolution of (3.9±0.7)´10-3. Finally, using the nFETs, we 
demonstrated the effectiveness of a custom polypeptide, p5, as a therapeutic agent in restoring 
the function of Cdk5. We expect that the straight-forward modifications to commercially sourced 
nFETs demonstrated here will lower the barrier to widespread adoption of these remote-gate 
devices and enable sensitive bioanalytical measurements for high throughput screening in drug 
discovery and precision medicine applications. 
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Introduction 
Field-effect transistors (FETs) have a long history as sensitive and label-free bioanalytical 
tools.1,2 Since that time FETs have been adapted for numerous applications that include 
measurements of protein-ligand interactions,3 monitoring of ocean acidification,4 low-cost DNA 
sequencing,5 enzyme measurements,6-8 and the detection of ionic action potentials in nerve and 
other neuronal systems.9,10 In most cases, the FET-based sensors are fabricated by leveraging 
nanomanufacturing processes that underpin the silicon-based complementary metal-oxide semi-
conductor (CMOS) industry. More recently, the emergence of 2D semi-conducting materials has 
resulted in new FET-based chemical sensors,11,12 and novel device geometries such as dual-gate 
FETs, which provide »100-fold higher sensitivity than silicon devices, while simultaneously 
improving the signal-to-noise ratio (SNR) of the measurements.8,13 
The sensitivity and resolution of pH measurements are important metrics of device function 
and are used, in particular, to validate the performance of new FET structures and designs.8,14,15 
Traditional ion sensitive field-effect transistors (ISFET) technology has been optimized to return 
a pH sensitivity that approaches the Nernst value of 59.5 mV when the solution pH changes by 1 
at room temperature.16 Efforts to improve the sensitivity of pH measurements have led to the 
exploration of dual-gate FETs for signal readout, which leverage the asymmetric capacitive 
coupling between the top- and back-gate with the device channel to amplify small pH signals 
measured remotely using commercial sensing elements. Recent measurements based on this 
approach have demonstrated the amplification of pH signals by 2-fold with silicon devices15 and 
37-fold (sensitivity of 2.25 V)17 to 75-fold (sensitivity of 4.4 V)8 higher than the Nernst 
sensitivity by using novel channel materials and gate structures. However, the improvement in 
sensitivity does not always result in better pH resolution for silicon devices because the noise 
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level increases with the signal, as seen from recent theoretical18 and experimental studies.15 As a 
result, the pH resolution of silicon ISFETs range from 50´10-3 for commercial ISFETs4 to as low 
as 15´10-3 for silicon nanowire devices.19 On the other hand, dual-gate FETs fabricated with a 
2D MoS2 channel and with a room temperature ionic liquid top-gate dielectric have been 
demonstrated with a pH resolution as small as 92´10-6 with a 10 Hz bandwidth.8 In particular, 
these devices, which were operated in a low-noise regime of the atomically thin channel, exhibit 
a linear scaling in pH resolution improvement with device gain.  
In order to drive adoption of high-resolution FET measurements within bioanalytical 
applications, we show how techniques developed for dual-gate FETs can be applied to 
commercially sourced silicon FETs. The techniques allow silicon devices to achieve pH readout 
resolution that exceeds most ISFET results and is on par with a solid-state version of recently 
published dual-gate 2D FETs (dg2DFETs).8 Importantly, the improved performance of both 
nFETs and dg2DFETs was achieved in a remote sensing configuration where the pH sensitive 
surface is located off-chip and connected electrically to the FETs. The advantage of the remote 
sensing approach is the separation of signal transduction from the sensing surface. This allows 
reuse of the electronic components, minimizes parasitic noise sources, and enables 
measurements from myriad commercial and custom-built sensing elements. This setup also 
differs from most ISFET studies where the gate dielectric also serves as the pH sensing 
membrane.  
We illustrate high-resolution pH measurements by comparing closed loop transduction of the 
signal from a commercial nFET to the open loop operation of the same device. The improved 
performance observed in the closed loop configuration establishes that this approach can allow 
the use of readily obtained commercially packaged transistors for laboratory grade bioanalytical 
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measurements. Furthermore, the closed loop transduction approach can be applied to a wide 
range of sensor technologies that could be based on other stand-alone transistors such as junction 
FETs (JFETs) and bipolar junction transistors (BJTs) and even to integrated sensors such as 
ISFETs. It is expected that this readout approach will improve the performance of sensor systems 
based on any of these transistors. The technique is demonstrated through measurements of the 
activity and the effect of customized polypeptide therapeutics on the kinase Cdk5, which is 
implicated in Alzheimer’s disease and numerous other debilitating neurological disorders. 
 
Experimental 
n-Channel Silicon Field-Effect Transistors: Commercially sourced (ALD110900PAL; 
Advanced Linear Devices, Sunnyvale, CA)† silicon n-channel field-effect transistors (nFETs) were 
soldered onto a printed circuit board (PCB) prior to measurements using a commercial probe 
station. Electrical characterization of the nFETs was performed using a semiconductor parameter 
analyzer (4155C; Agilent. Santa Clara, CA). Time-series measurements with the nFETs were 
performed similarly to the measurements done with dg2DFET as described below. 
2D Dual-Gate Transistor Fabrication: A detailed description of the device fabrication process 
and monolayer characterization for dual-gate 2D field-effect transistors (dg2DFETs) was provided 
in our previous work.8,13,20 Briefly, monolayer MoS2 was first transferred onto an oxidized Si 
substrate (SiO2 with a thickness of 70 nm) by using a gold-mediated exfoliation technique.21 The 
thickness of the transferred material was confirmed with Raman spectroscopy.13 Optical 
lithography was used to first pattern the source (S) and drain (D) contacts followed by electron-
beam metal deposition (80 nm Au on 2 nm Ti) and lift-off in acetone. A second optical lithography 
step was then used to define and etch a 5 μm ´ 5 μm channel for each FET. The devices were then 
annealed under forming gas (5 % H2, 95 % Ar) for 24 hours to minimize organic contamination 
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and improve the contact resistance.13 This was immediately followed by the atomic layer 
deposition (ALD) of a 20 nm top-gate (TG) Al2O3 dielectric. Finally, another optical lithography 
step was used to pattern the top-gate metal, followed by electron-beam metal deposition (100 nm 
Au on 10 nm Ti) and lift-off in acetone.  
Remote Biological Activity Measurements: The enzyme and pH calibration measurements 
were performed with the nFETs and dg2DFETs were performed by connecting a pH sensor to 
the top-gate metal contact with a shielded coaxial cable. This remote sensing approach allows 
electronic components to be separated from the biological components and thereby reused. In the 
present work, a glass combination microelectrode (MI-4156; Microelectrodes, Bedford, NH) 
capable of measurement volumes as small as 50 µL was used as the pH sensor, although the 
techniques described here are compatible with other sensing and bioanalytical surfaces that can 
be electrically connected to the top-gate metal contact. 
Time-Series Field-Effect Transistor Measurements and PID Control: Time-series 
measurements were performed by operating the nFETs and dg2DFETs under proportional-
integral-derivative (PID) control (HF2LI; Zurich Instruments, Zurich, Switzerland).  The channel 
current, ID, was maintained at a constant value by continuously varying the back-gate voltage 
(VBG) in the case of the dg2DFETs or by adding the controller output to the signal from the pH 
sensor (VpH)  for the nFETs in response to changes in the top-gate potential.  
The PID control system was implemented by first amplifying the channel current, ID, with a 
current preamplifier (DLPCA-200; FEMTO, Berlin, Germany) at a gain of either 106 V/A 
(dg2DFET) or 103 V/A (nFET). The output of the current preamplifier was then filtered through 
a 4-pole Bessel filter with a cutoff frequency of 5 kHz and sampled with a frequency of 25 kHz 
by using a 14-bit analog-to-digital converter (HF2LI; Zurich Instruments, Zurich, Switzerland). 
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The digital PID controller (KP=553.5 mV, KI=9.22´103 s-1 and KD=10.4 µs) was operated with a 
bandwidth of 1 kHz to maintain the channel current set-point. Because most biological processes 
are slow and do not require high bandwidth measurements, the controller output was further 
filtered by using a low-pass filter with a cutoff frequency of 10 Hz prior to being recorded. 
Sensitivity and Resolution of pH Measurements: The pH sensitivity and resolution were 
established as described in our previous work.8 Briefly, a histogram from the raw VPID time-
series data was computed for each measured pH. A sum of two Gaussian distribution functions 
was then fit to the histograms to obtain the peak positions and standard deviations of the 
reference potential and the measured pH signal. The difference in the peak positions between the 
pH and reference potentials (DVPID) was used to determine the pH sensitivity of the device. The 
measurement uncertainty (sPID) was then obtained by propagating the error when determining 
DVPID. For the nFETs, the pH resolution, DpH=(k´sPID)/VNernst, is reported with expanded 
uncertainty (k=2), where VNernst is the Nernst potential at room temperature. For the dg2DFETs, 
DpH=(k´sPID)/(a´VNernst), where a is the device gain. 
Kinase Measurement Reagents: The activity of Cdk5/p25 was estimated by measuring the 
phosphorylation of histone H1 as reported previously.8 All measurements were performed with 
18.5 nM of Cdk5/p25 (C0745; Sigma Aldrich, MO) in 1´ kinase buffer to match physiological 
conditions using a volume of 50 µL. The substrate protein histone H1 (10223549001; Sigma 
Aldrich, MO) was suspended in deionized water at a stock concentration of 2 mg/mL and further 
diluted as described in the in the Results section.  Substrate phosphorylation was initiated with a 
mixture of dithiothreitol (DTT) and adenosine triphosphate (ATP) with final concentrations of 
250 µM and 5 mM respectively. The measurements were buffered using 5´ kinase buffer, 
prepared by suspending 25 mM b-glycerol (G9422; Sigma Aldrich, MO), 50 mM MgCl2 (5980; 
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Millipore, MA), 5 mM EGTA (E0396; Sigma Aldrich, MO), 2.4 mM EDTA (1002264786; 
Sigma Aldrich, MO), 1.25 mM MOPS (M1254; Sigma Aldrich, MO) in deionized water (DIW). 
The kinase buffer was then diluted in DIW to form the 1´ kinase buffer used in the assays. 
 
Results and Discussion 
We electrically characterized nFET and dg2DFET devices to evaluate their performance and 
to determine the optimal operating conditions for biosensing applications. The devices were 
calibrated with standard pH buffer solutions to determine the gain, α, of the dg2DFET, and the 
noise performance, sensitivity, and resolution of both the nFETs and the dg2DFETs. Finally, 
both device types were used to measure the activity of the kinase Cdk5, an enzyme implicated in 
Alzheimer’s disease, and to evaluate the effectiveness of a custom polypeptide, p5, as a 
therapeutic agent in modulating Cdk5 function. 
Silicon n-Channel FET Performance. The nFETs (Fig. 1a; right) were first characterized 
electrically using the configuration shown in the schematic in Fig. 1a (left). The transfer 
characteristics of the device were determined by recording the drain current (ID) as a function of 
the gate potential (VG), while the drain voltage (VD) was held constant. Fig. 1b shows the typical 
transfer characteristics (ID¾VG) for the nFETs. The device exhibits up to »8 orders of magnitude 
change in ID when switching from an off-state to an on-state with a steep sub-threshold slope of 
»100 mV per decade at »300 K and gate leakage current (IG) of »1 pA. Fig. 1b (inset) shows the 
transconductance (gm), obtained by taking the numerical derivative of the transfer curve. The 
peak transconductance of the nFETs (gm,peak) was found to be »78 µS at a voltage (Vgm,max) of 
0.385 V. 
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Figure 1: Electrical characterization of a commercially sourced silicon n-channel field-effect transistor 
(nFET) for biosensing applications. (a) left: Schematic of the electrical characterization setup of the nFET. 
A constant voltage, VD, is applied to the drain contact while the source is grounded. The transfer 
characteristics of the device are obtained by sweeping the top-gate voltage, VG, to electrostatically control 
the channel current (ID). right:  An image of the packaged nFET used in this work. (b) The transfer curve 
of the nFET is shown by measuring ID as a function of a sweep of VG. The sub-threshold slope was found 
to be 100 mV per decade. (inset) The device transconductance as a function of VG. The voltage at peak 
transconductance determines the point of maximum sensitivity and is used to optimally bias the device for 
biosensing.   
 
pH Sensitivity Using n-Channel Silicon Transistors. The pH sensitivity of the nFETs was 
measured by using commercial standard pH buffer solutions over a range of 4 to 10. When 
operating the device in an open loop, shown schematically in Fig. 2a, we found the pH response 
to be linear when the device was operated about gm,peak as seen in Fig. 2b (blue). This behavior is 
expected when operating the device in the linear regime of the transfer curve (see Fig. 1). Under 
these conditions, we found the pH sensitivity, dID/dpH»6 µA (R2=0.992) when VD=0.1 V, 
yielding a transimpedance gain of 9.9´103 V/A, assuming VNernst of 59.5 mV at room 
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temperature (300 K). The pH response was drastically different, as expected, when the device 
was operated about its threshold voltage (VT =0 V) as seen from Fig. 2b (pink and inset). In this 
case, the pH response was linear under acidic conditions (pH < 7), when the pH sensor returned a 
positive potential, thereby driving the FET into the inversion regime. On the other hand, under 
more basic conditions (pH > 7), the sensor potential was negative causing the nFET to operate in 
the sub-threshold regime where the current decreases exponentially at negative gate potential. 
The net result is a pH response that is highly non-linear over the measured pH range as has been 
observed by others in the literature.22 Therefore, it may be advantageous to operate the nFET in 
the linear regime, particularly when operating over a wide pH range. Additionally, the larger ID 
in the linear regime over its value at VT results in lower relative noise and improved pH 
resolution as will be discussed in greater detail in later sections. 
 
Figure 2: Calibration of pH measured with a commercially sourced n-channel silicon field-effect transistor 
(nFET). (a) The nFET was operated in open loop by directly measuring the changes in the drain current 
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(ID) due to changes in the gate potential (VTG) applied to the top-gate contact (G). A constant offset 
potential (Vo) was summed with the potential (VpH) generated by a glass pH microelectrode prior to being 
applied to the gate contact. (b) The change in ID as a function of measuring standard pH buffer solutions 
ranging from pH 4 to pH 10 with a glass pH microelectrode. Setting Vo to operate the device at peak 
transconductance (gm,peak) resulted in a linear response over the measured pH range (blue). Operating 
the device about the threshold voltage (VT) of 0 V resulted in a highly non-linear pH response (pink and 
inset). (c) Constant current mode operation of the FET was performed by using a proportional-integral-
derivative (PID) controller to monitor ID and continually adjust the PID voltage (VPID). VPID was summed 
with VpH prior to being applied to the gate contact. (d) The change in VPID as a function of measuring 
standard pH buffer solutions ranging from pH 4 to pH 10 using a glass pH microelectrode. The PID set-
point was set to a value of ID to allow device operation either at gm,peak (blue) or at the threshold voltage of 
0 V (pink). Note that the error bars are smaller than the open circles that represent the data points. The 
error bars in (b) and (d) represent the expanded uncertainty (k=2) of the measurand.  
 
The sensitivity and performance of the commercial nFET improved considerably when 
operated under closed loop PID control as shown schematically in Fig. 2c. In this configuration, 
the controller continually adds a control voltage (VPID) to VpH, thereby maintaining ID at a 
constant value. A key advantage of this approach is that because the device will always operate 
at the same point in its transfer curve (see Fig. 1b), its performance remains consistent across a 
wide range of measured pH values. This is clearly seen in Fig. 2d, where the device exhibits a 
linear pH response both when the PID controller was set up to hold the nFET at gm,peak (blue) and 
when the device was operating at its VT of 0 V (pink). Furthermore, the pH sensitivity in both 
cases, dVPID/dpH»56 mV (R2=0.997), was obtained from a linear regression of the curves in 
Fig. 2d and approached the Nernst value of 59.5 mV at room temperature. Finally, the remote 
sensing configuration used here allows the PID output to be summed with the sensor signal, 
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allowing the controller to operate at a higher bandwidth and allowing better noise suppression, 
thereby improving pH resolution.  
Dual-Gate 2D FET Performance. We compared the performance of the nFETs with that of 
dg2DFETs that we fabricated from atomically thin MoS2 films. An optical image of a 
representative dg2DFET device is shown in Fig. 3b. The dg2DFETs were electrically 
characterized following fabrication by using the setup shown schematically in Fig. 3a. The 
transfer characteristics of the device were measured by recording the drain current (ID) as a 
function of the top-gate potential (VTG) with the drain voltage (VD) held constant (Fig. 3c). The 
measurements were repeated for different VBG to determine the signal amplification (a) due to 
the asymmetric capacitance of the top and back gates.8 The devices exhibited a dynamic range of 
up to »5 orders of magnitude in ID and a subthreshold slope of »800 mV per decade, consistent 
with expected behavior for a 20 nm high-k Al2O3 gate dielectric.  
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Figure 3: Electrical characterization of dual-gated monolayer MoS2 field-effect transistors (FETs) for 
biological sensing applications. (a) Measurement schematic for characterizing a dual-gated 2D-FET for 
remote biosensing. The MoS2 2D semi-conducting channel spans the source (S) and drain (D) contacts. 
While the source contact is grounded, a constant potential (VD) is applied to the drain contact driving a 
current across the 2D channel. The channel conduction is electrostatically controlled by a voltage applied 
to the silicon substrate, which forms the global back-gate (B) or to the metal top-gate (G). (b) Top view 
optical image of an array of 2D MoS2 FETs. (c) Transfer characteristics of a dual-gated 2D FET showing 
drain current (ID) as function of the top-gate voltage (VTG) while stepping back-gate voltage (VBG). (d) The 
change in VBG as function of top-gate threshold voltage (Vt,TG) is shown. A linear regression to the data 
(n=5) is used to determine the signal amplification (a) of VTG at the back-gate. The error bars report the 
standard error defined as the standard deviation of the population mean. 
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For each curve in Fig. 3c, the top-gate threshold voltage (Vt,LG) was determined from a linear 
extrapolation of ID(VTG) at the voltage corresponding to peak transconductance to ID=0.23 Fig. 3d 
plots the back-gate voltage (VBG) against the top-gate threshold voltage (Vt,TG). This allowed the 
determination of the device gain from the expression a=dVBG/dVt,TG.8 The value of a for devices 
measured as part of this work was then determined numerically from a linear regression to the 
data in Fig. 3d, resulting in a=8±1, or »4 times larger than state-of-the-art dual-gate silicon 
devices.15 The measured value of a is in good agreement with theoretical predictions for devices 
with a 20 nm Al2O3 top-gate dielectric and 70 nm SiO2 bottom oxide.  
It is important to note that the dg2DFETs presented here do not operate in the quantum 
capacitance limited regime as we showed previously with dual-gated ionic liquid devices.8 This 
is due to the fact that, in the inversion regime where the dg2DFETs operate, the top-and back-
gate capacitances (CTG»0.4 µF/cm2 and CBG»0.05 µF/cm2) are more than an order of magnitude 
smaller than the quantum capacitance (CQ»4 µF/cm2) of the 2D channel.24,25 This allows us to 
ignore the effects of CQ, giving rise to the simplified expression for the device gain, 
a=dVBG/dVt,LG=CTG/CBG (see Ref. 8 for a detailed derivation). 
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Figure 4: Electrical calibration and pH sensitivity measurements of dual-gate 2D field-effect transistors 
(dg2DFETs) when operated in a constant current mode. (a) Schematic representation of constant current 
mode operation of dg2DFETs.8 A proportional-integral- derivative (PID) controller was used to maintain 
the channel current (ID) at a constant value. Control of ID was achieved by continually adjusting the back-
gate voltage (VBG) in response to changes in the top-gate potential (VTG) applied either using a waveform 
generator or from the output of a pH sensor (Vsig). A DC offset voltage (Vo) was summed with Vsig to 
determine the optimal operation region of the dg2DFET.  (b) The time-variant response of VBG under PID 
control is shown when the top-gate is biased with a 1 Hz AC sine wave signal with a peak-to-peak 
amplitude of 200 mV. (c) Response of VBG when measuring standard buffer solutions from pH 4 to 10. 
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The error bars represent the expanded uncertainty (k=2) of the measurement. Note that the error bars are 
smaller than the open circles that represent the data points. (inset) Time-series data, relative to a 
reference potential value, show the response of VBG when measuring standard buffer solutions from pH 4 
to 10.  
 
pH Sensitivity of Dual-Gate 2D FETs. The dg2DFETs were operated in a constant current 
mode as described in the Experimental section and shown schematically in Fig. 4a. A PID 
controller was used to maintain ID at a preset value by continuously varying VBG in response to 
changes in VTG. The controller current set-point (50 nA) and a DC offset voltage applied to the 
top gate (Vo=+0.5 V) were optimized to operate the device in the linear and low-noise region of 
the transconductance curves in Fig. 3c. The performance of the device was then validated by 
applying a sine wave at a frequency of 1 Hz and peak-to-peak amplitude of 200 mV to the top-
gate and measuring the response of VBG (Fig. 4b) as regulated by the PID controller. The device 
gain, a, was then obtained from the ratio of the amplitudes of VBG to VTG to yield a=5.8±0.1, 
consistent with the data in Fig. 3d. 
The pH sensitivity of the dg2DFETs was measured by remotely connecting a pH sensor to 
the top-gate metal contact with a shielded cable. A switch was used to alternatively either ground 
the top-gate or connect it to the pH sensor. Time-series measurements of the system response, 
under PID control, to commercial standard buffer solutions from pH 4 to pH 10 are shown in 
Fig. 4c (inset). The time-series data were analyzed as described in the Experimental section to 
yield the pH response curve in Fig. 4c with a sensitivity, dVBG/dpH= 236.3 mV (R2=0.998). 
Comparison of pH Resolution of n-Channel Silicon and Dual-Gate MoS2 Transistors. The 
pH resolution (DpH) of nFETs and dg2DFETs at a bandwidth of 10 Hz were determined when 
measuring phosphate buffered saline (PBS) and are summarized in Table 1. Following a 
procedure we developed previously,8 a switch was used to alternatively either connect the gate 
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terminal to the PBS solution or to ground. This method allowed the measurements of time-series 
of nFETs operated in an open loop as seen in Fig. 5a (inset). A histogram of the time-series was 
then used to determine the mean value of ID for each measured pH solution and the expanded 
uncertainty (k=2) as described in the Experimental section. As seen from Fig. 5a, a linear 
regression of the measured pH data yielded a sensitivity, dID/dpH»4 µA (R2=0.974) when 
VD=0.1 V, similar to the value obtained from the data in Fig. 2b. By inverting the curve and 
propagating the uncertainty in ID, we determined DpH with an expanded uncertainty (k=2) to be 
(22±2) ´ 10-3 at a bandwidth of 10 Hz in the open loop configuration. 
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Figure 5: A comparison of pH sensitivity and resolution between a commercially sourced n-channel silicon 
field-effect transistor (nFET) operating open loop, operating under closed loop proportional-integral-
derivative (PID) control, and a 2D dual-gated MoS2 transistor (dg2DFET) operating under closed loop PID 
control. All measurements were performed with a pH sensitive glass microelectrode. (a) The change in 
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the nFET channel current (DID) when operating the device in open loop, as a function of phosphate 
buffered saline (PBS) solutions adjusted to different pH values. The pH sensitivity in this case was 
dID/dpH»4 µA (R2=0.974) when the drain voltage, VD, was 0.1 V (b) The change in the PID control voltage 
(DVPID) as a function of solution pH when operating the nFET devices with PID control. In this case, the 
pH sensitivity was dVPID/dpH=58.7 mV (R2=0.988). (c) The change in the back-gate voltage, DVBG, as a 
function of solution pH when operating dg2DFETs under PID control. The pH sensitivity of the 
measurements, dVBG/dpH was found to be 384 mV (R2=0.999) (insets) Underlying time-series data from 
nFETs and dg2DFETs that were analyzed to obtain the plots in panels (a), (b) and (c). The error bars in 
all cases represent the expanded uncertainty (k=2) of the measured quantity shown on the y-axis of the 
plot. Note that in (b) and (c) the error bars are smaller than the open circles that represent the data points. 
The measurements were repeated when operating the nFET under PID control. The time-
series of the PID controller output (Fig. 5b, inset) were analyzed identically to the open loop data 
to yield a pH sensitivity, dVBG/dpH=58.7 mV (R2=0.988) as seen from Fig. 5b, consistent with 
the expected value of VNernst at room temperature. The error bars at each measured pH value, 
which represent the expanded uncertainty (k=2) in the PID output voltage, are a direct measure 
of DpH. We found that, on average, DpH=(7.2±0.3)´10-3 at a bandwidth of 10 Hz or an »3-fold 
improved over nFETs operating in open loop. 
Table 1: The smallest detectable pH change (DpH) of phosphate buffered saline solution measured with a 
bandwidth of 10 Hz. The values were determined from the error bars reported in Fig. 5. 
 Nominal pH 6.72 6.81 6.88 6.96 7.05 
DpH nFETopen-loop 0.018 0.027 0.024 0.019 0.025 
DpH nFETPID 0.006 0.007 0.008 0.007 0.008 
DpH dg2DFETPID 0.003 0.003 0.006 0.005 0.002 
 
Both modes of nFET operation described above were compared with pH measurements 
performed by using dg2DFETs in a closed loop configuration. Fig. 5c (inset) shows time-series 
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measurements of the pH sensitivity of PBS buffers acquired by dg2DFETs when they were 
operated using the PID control scheme in Fig. 4a. An analysis of the pH time-series (see 
Experimental section for details) yielded a sensitivity, dVBG/dpH=384 mV (R2=0.999) as seen 
from Fig. 5c, which represents an »6.5-fold amplification of VNernst at room temperature. The 
error bars in the figure estimate the expanded uncertainty (k=2) of the DVBG at each pH value. 
This in turn allowed the estimation of the pH resolution from the expression 
DpH=DVBG/(a´VNernst)=(3.9±0.7)´10-3 at a bandwidth of 10 Hz, or »2-fold better than the nFET 
devices operating under PID control. 
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Figure 6: (a) A comparison of the pH resolution (DpH) as a function of pH when operating the n-channel 
silicon field-effect transistor (nFET) in open loop (blue), the nFET under PID control (pink) and the 2D 
dual-gated MoS2 transistor (dg2DFET) under PID control (green). (b) Power spectral density (PSD) of the 
channel current, ID, of nFETs under open loop operation (blue) and under PID control (pink). (c) Power 
spectral density (PSD) of the channel current, ID, of dg2DFETs s under open loop operation (blue) and 
under PID control (pink). 
 
As seen from Fig. 6a (blue and pink) and Table 1, the pH resolution of nFETs can be 
substantially improved by operating them under PID control. Under this mode of operation, the 
low intrinsic noise and the high channel currents of the nFETs allow their performance to 
approach that of custom-built dg2DFETs (Fig. 6a, green). To better understand the improvement 
in nFET performance under PID control, we measured the power spectral density (PSD) of the 
channel current noise, SID, as seen in Fig. 6b. Under open loop operation (Fig. 6b, blue), the 
devices exhibit 1/f noise scaling as observed by others in the literature.15,26 The root mean 
squared (RMS) noise in the channel current (dID) was then determined from the expression 
"∫ 𝑆%& 𝑑𝑓	*+  to be 2.5 nA in the open loop case for a bandwidth of 10 Hz. The PID controller 
greatly suppresses 1/f noise as seen from Fig. 6b (pink). When operating under PID control, we 
found dID to be 0.18 nA, or an order of magnitude lower for a bandwidth of 10 Hz. This 
reduction directly results in the improved DpH seen in Fig. 6a (blue and pink). 
An improvement in the channel current noise is also observed for the dg2DFETs when 
operating under PID control, in comparison with the open loop case, as seen from Fig. 6c. At a 
bandwidth of 10 Hz, dID decreased from 7.0 pA for open loop operation to 2.1 pA when 
operating under PID control. However, in contrast to the nFETs, the dual-gate devices have an 
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intrinsic gain of »6.5, which improves their overall performance. In order to directly compare the 
nFETs with dg2DFETs when both devices were operating under PID control, we determined the 
relative noise for each case as dID/ID, where the channel current, ID, is also the current set-point 
for the PID controller. For the nFETs this value was 40.5 µA to allow operation at gm,peak, and 
50 nA for the dg2DFETs. This results in dID/ID=4.3´10-6 for the nFETs, and dID/ID=4.2´10-5 for 
the dg2DFETs. The order of magnitude lower relative noise in the nFETs is offset by the gain, a, 
resulting from the dual-gated structure of the dg2DFETs and is consistent with the measured 
improvement in DpH seen in Fig. 6a (nFETPID; pink and dg2DFETPID; green). Furthermore, as 
noted earlier, the remote sensing configuration and the use of commercial devices for signal 
transduction implies that the performance of this system can be continually improved by 
substituting the existing commercial FETs with other lower noise devices, which in turn can 
improve DpH. 
While the pH resolution of the nFETs can approach that of the dg2DFETs with a moderate 
internal gain, their performance is expected to fall short of high gain devices such as ionic liquid  
gated dual-gate FETs.8 The highly asymmetric gate geometries of the ionic liquid gated FETs 
allows the realization of a>150 while operating in a low-noise regime similar to the dg2DFETs. 
The combination of high gain and low noise allows those devices to resolve pH values as small 
as 92´10-6, which is an order of magnitude below the resolution attainable by the dg2DFETs 
(Fig. 6a). While this improved resolution is critical in certain bioanalytical applications, we show 
below that the improvements in the operation modes of nFETs demonstrated here can be 
leveraged to measure both enzymatic activity and the effect of therapeutics on enzyme function 
at physiological concentrations. 
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Cdk5-p25 Pathological Activity and Neurodegeneration. The cyclin-dependent kinase 5 (Cdk5) 
is of fundamental importance for neuronal development, memory and pain signaling.27-30 Its 
physiological activators, the proteins p35 and p39, trigger the Cdk5-mediated phosphorylation of 
neuronal proteins and organelles that are essential for the normal function of the human nervous 
system.31-33 Numerous factors, which include environment, lifestyle and genetics, result in an 
increased uptake of intracellular Ca2+ that activates the protease calpain, truncating p35 into the 
fragments p10 and p25. The latter is a pathological activator of Cdk5, leading to its 
hyperactivation. Multiple cascading effects within the cell cycle can be traced back to the 
hyperactivation of Cdk5 resulting in the formation of β-amyloid plaques and intracellular 
neurofibrillary tangles – the well-known indicators of neurodegenerative diseases such as 
Alzheimer’s disease (AD).34-40 
Therapeutic approaches targeting Cdk5-related pathologies have focused on inhibitors such as 
aminothizole and roscovitine, which bind to the ATP-docking pocket and prevent Cdk5-mediated 
hyperphosphorylation.41-44 However, targeting the ATP-binding pocket also causes non-specific 
interactions with other ATP-mediated cellular reactions, often causing serious side-effects. This 
has led to the pursuit of alternative approaches, such as the use of cholinesterase inhibitors45 or 
antioxidants,46,47 which have thus far not resulted in safe therapeutics.  
In past work, we have shown a novel approach to inhibit the Cdk5-p25 pathology,37 for 
example using the 24 amino acid, p5, obtained through the repeated truncation of p35. Importantly, 
these polypeptides act as selective inhibitors of Cdk5 pathological hyperactivity in both in vivo 
and in vitro experiments.37,48,49 A variant derived from p5, TFP5, which was designed to cross the 
blood-brain barrier 50 showed a drastic decrease in pathology by allowing the rescue of cortical 
neurons in transgenic 5XFAD AD model mice in vivo.40,50  
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Figure 7: Measurements of the activity of the proline directed kinase, Cdk5 and the effect of the custom 
designed therapeutic polypeptide, p5, on modulating its activity. (a) (top) The molecular structure of the 
pathological Cdk5/p25 complex when phosphorylating a substrate protein, histone H1, during adenosine 
triphosphate (ATP) hydrolysis. (bottom) The reaction scheme of Cdk5-mediated phosphorylation of serine 
or threonine residues in histone. Upon hydrolysis of ATP, a single proton is released causing a slight 
acidification of the surrounding medium. (b) The change in the measured gate voltage (DVPID) of a n-
channel silicon field-effect transistor (nFET) upon Cdk5-mediated phosphorylation as a function of the 
substrate protein, histone H1, concentration ([H1]).  The solid line shows the fit of a Langmuir adsorption 
model to the data, which returned an activity coefficient, ka=(8.2±1.3) µM (c) Molecular representation of 
p5 interactions with the Cdk5/p25 complex that result in a decrease in its activity. (d) DVPID as function of 
p5 concentration ([p5]) shows decreasing Cdk5 activity. The concentration of Cdk5/p25 and histone H1 
were held a fixed value for each measurement in the plot. The solid line plots an exponential function to 
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illustrate the trend in the data. The error bars in (b) and (d) represent the expanded uncertainty (k=2) in 
DVPID. 
 
In ongoing work, we have used computer simulations to determine the molecular basis of p5-
based inhibition mechanisms – a critical step towards developing safe therapeutics for the 
regulation of Cdk5/p25 hyperactivity.51 This in turn could also lead to new molecules that are more 
selective and therefore safer. The FET-based measurements developed here can play a central role 
in this development cycle by enabling the rapid testing of candidate molecules. As a first step 
towards this goal, we demonstrate the ability of nFETs to measure the activity of Cdk5/p25 and 
the effect of p5 on re-regulation of this enzyme under physiological conditions. 
Enzymatic Activity of the Pathological Cdk5-P25 Complex. Fig. 7a shows a molecular 
representation (protein data bank structure: 1UNL52) of the Cdk5-mediated phosphorylation (top) 
and the phosphorylation reaction scheme (bottom). In the presence of an activator protein (e.g., the 
pathological p25), Cdk5 catalyzes the transfer of a single phosphate group from ATP to a serine 
or threonine residue in a substrate protein (e.g., histone H1). The reaction also releases a single 
proton, thereby causing the surrounding medium to become slightly more acidic and decreasing 
its pH. When using the nFETs, the change in pH resulted in a change in VPID relative to a control 
sample with no enzyme, for concentrations of histone ([H1]) ranging from 9 µM to 25 µM as 
shown in Fig. 7b. All measurements were performed at a physiological concentration of Cdk5/p25 
of 18.5 nM. As expected, the change in VPID increased monotonically with increasing histone 
concentration. A simple model of the form 𝛾 [./]123[./], where ka is the activity and g is a scaling 
constant, was fit to the data in Fig. 7b. The value of ka was then estimated to be (8.2±1.3) µM when 
measured with the nFETs. This value was consistent with ka=(9.1±0.9) µM for measurements 
performed using dg2DFET-based sensors (Fig. S1) under identical solution conditions, and also 
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in agreement with our previous measurements using a g-32P-ATP assay (ka=12.1±2.3 µM) as seen 
from Fig. S2.8 In each case, the error bars of the estimated quantity represent the standard error of 
the measurement. 
We leveraged the high time-resolution of our technique to measure the kinetics of the 
Cdk5/p25 enzymatic reaction for histone concentrations of 9.1 µM, 12.7 µM and 18.2 µM as seen 
from Fig. S3. In each case, the reaction was initiated upon the addition of ATP. After »1 minute, 
we observed a distinct change in the voltage signal that was indicative of histone phosphorylation. 
A control sample with no Cdk5/p25 showed no change in signal upon the addition of ATP. A 
nonlinear regression of the form 𝛽(1 − 𝑒91:;), where b is a scaling constant, was used to estimate 
the enzyme rate constant k1 to be (0.35±0.1) min-1, consistent with literature values.53  
Inhibition of Cdk5/p25 activity with p5. Upon the addition of the 24 amino acid polypeptide p5, 
we observed a strong reduction in Cdk5/p25 activity. A plausible structure of the complex formed 
between p5 and Cdk5/p25, derived from our previous computer simulations,51 is shown in Fig. 7c. 
However, the molecular and regulatory mechanism of p5 action on Cdk5/p25 activity is still under 
investigation. As in Fig. 7b, the measurements were performed with a Cdk5/p25 concentration of 
18.5 nM and a histone concentration of 25.4 µM. Fig. 7d shows the change in VPID when the p5 
concentration ([p5]) was increased from 0.25 µM to 1.2 µM. From the figure, we can clearly see 
the effect of p5-based inhibition. Furthermore, the measurements agree with previous results of 
the interaction of p5 with the Cdk5/p25 complex obtained using a g-32P-ATP assay.37 In particular, 
the sharp decrease in Cdk5/p25 activity past [p5]=0.7 µM. This decrease is indicative of a specific 
threshold for p5 inhibition and will be studied further in future work.  
 
 
 27 
 
Conclusions 
We show that the operation of commercially sourced nFETs can be optimized to achieve a pH 
resolution of (7.2±0.3)´10-3, »3-fold better than traditional ISFETs, and on par with solid-state 
dg2DFETs with an intrinsic gain a=8. Furthermore, the improved performance is attained when 
the devices are operated in a remote configuration, with the pH sensing element located off-chip 
and connected electrically to the FET. This remote sensing approach is in contrast to 
conventional ISFETs which use integrated pH sensing membranes that form the gate dielectric. 
Our design greatly increases the versatility of nFETs in sensing applications, allowing them to be 
rapidly and easily interfaced with different biochemical sensors. It also allows the easy 
integration of other transduction elements into the biosensing setup that can be customized to 
meet the sensitivity, resolution and other performance needs of individual applications. Finally, 
the techniques outlined here can also be used to benefit applications that require integrated 
sensing, for example by improving the performance of traditional ISFETs.  
The improved performance of the nFETs, operated in a remote configuration, was shown to 
be adequate to measure the activity of a pathological form of the proline directed kinase, Cdk5, 
which has been implicated to cause numerous neurodegenerative conditions including 
Alzheimer’s disease. By using nFET-based measurements, we confirmed the effectiveness of a 
custom polypeptide, p5, in re-regulating Cdk5 function. Together the measurements demonstrate 
the feasibility of performing sensitive bioanalytical measurements with commercially available 
FETs, thereby drastically lowering the barrier to the adoption of this sensing technology. 
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